Laddar...

Mutated Nucleophosmin-1 (NPM1) in patients with Acute Myeloid Leukemia (AML) in remission and relapse

Patients with newly diagnosed AML (n=360) including 137 (38%) with normal karyotype (NK) were evaluated. Overall, 60 (16.6%) patients including 46 of the 137 (33.5%) NK patients had NPM1 mutation at baseline. Thirty nine patients (30 NK) had available NPM1 status at the time of CR and all (100%) wer...

Full beskrivning

Sparad:

Bibliografiska uppgifter
Huvudupphovsmän:	Jain, Preetesh, Kantarjian, Hagop, Patel, Keyur, Faderl, Stefan, Garcia-Manero, Guillermo, Benjamini, Ohad, Borthakur, Gautam, Pemmaraju, Naveen, Kadia, Tapan, Daver, Naval, Nazha, Aziz, Luthra, Raja, Pierce, Sherry, Cortes, Jorge, Ravandi, Farhad
Materialtyp:	Artigo
Språk:	Inglês
Publicerad:	2013
Ämnen:	Article
Länkar:	https://ncbi.nlm.nih.gov/pmc/articles/PMC4143910/ https://ncbi.nlm.nih.gov/pubmed/24004182 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10428194.2013.840776
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!

Mutated Nucleophosmin-1 (NPM1) in patients with Acute Myeloid Leukemia (AML) in remission and relapse

Liknande verk